The TB online course is intended as a self-study refresher course for physicians (both public and private) that may be involved in the management and care of patients with TB. This course includes many aspects of TB care and management with a global scope so that it may be used across regions. The course is developed as a preparation course to the MDR-TB course of WMA and both courses together offers a complete training module on TB.
The course provides basic clinical care information for TB including the latest diagnostics, treatment and information about multidrug-resistant TB. It also provides information on how to ensure patient adherence and infection control and will include many aspects of TB care and management with a global scope so that it can be used across regions.
The course is based on the International Standards for Tuberculosis Care (ISTC), which presents a set of widely accepted, evidence-based standards that all practitioners, public and private, should seek to achieve. The course also refers to and is consistent with the World Health Organization (WHO) Guidelines and recommendations for TB control.
Since there are variations in policy and guidelines by country, the course cannot reflect country- specific regulations. This course presents general principles of TB control. Just as the ISTC, this course is intended to complement, not replace, national, and international guidelines. For specific details about local policies, you should refer to your national TB control guidelines.
Instruction: Read through each section and complete the question and answer sections at the end of each section and review any information that you did not understand. You are encouraged to use the references provided through the links to get more detailed information on specific topics.
and technical support from the New Jersey Medical School Global Tuberculosis Institute.
The World Medical Association gratefully acknowledges:
The Eli Lilly MDR-TB Partnership for a generous unrestricted educational grant and a tireless coordination of the humanitarian efforts in the NGO community to fight TB.
The health care providers and other experts who participated in review and field testing of the course:
Dr. Laura Brandt, International Training and Education Center on HIV, Namibia Dr. Cassandra Butu, WHO - Romania Dennis Falzon, WHO, Switzerland Dr. Nzali Kancheya, Centre for Infectious Disease Research, Zambia Dr. Vaira Leimane, WHO Coordinating Center, Latvia Dr. Chih-Bin Lin, Buddhist Tzu Chi General Hospital, Taiwan Dr. Sundari Mase, CDC Division of Tuberculosis Elimination, USA Dr.Nikoloz Nasidze, Medical Service Corporation International, Georgia Alice Njorage, Eastern Deanery AIDS &Relief Program, Kenya Dr. Hernan Reyes, ICRC, Switzerland Dr. Nelly Solomonia, National Centre for Tuberculosis and Lung Diseases, Georgia Prof. Anton Stoltz, Health Science / Economics & Business Studies Faculties, South Africa
The following persons and organizations involved in development of this course:
Julia Seyer, World Medical Association for the overall organisation of this project Tengel Sandtro, Norwegian Medical Association Nisha Ahamed, NJMS Global Tuberculosis Institute Miguel Bernal, HELP Design Group Dr. Patrizia Carlevaro, Lilly MDR-TB Partnership Alka Dev, Independent TB Consultant Dr. Alfred Lardizabal, NJMS Global Tuberculosis Institute Dr. Bonita T. Mangura, NJMS Global Tuberculosis Institute Eileen Napolitano, NJMS Global Tuberculosis Institute Tristan Piguet, Lilly MDR-TB Partnership Dr. Lee B. Reichman, NJMS Global Tuberculosis Institute Move right Move Update Delete Hide Disclaimer:
All reasonable precautions have been taken by the World Medical Association and the NJMS Global Tuberculosis Institute to verify the information contained in this publication. However this course is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Medical Association or the NJMS Global Tuberculosis Institute be liable for damages arising from its use. As research and experience with TB progress we do expect that WHO will update it’s guidelines. We do our best to incorporate changes into the course, however please visit the WHO web page to check for the latest versions of the guidelines.